Tokyo Tape
Sign in
← ASKA Pharmaceutical Holdings

Annual report

4886.TEDINET S100OHVN
Period2021-04-01 → 2022-03-31
Filed2022-06-28
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 37
MetricValuePeriodScopeSource row
Revenue¥56.6bn2021-04-01 → 2022-03-31Cons.Net sales
Operating income¥4.8bn2021-04-01 → 2022-03-31Cons.Operating income
Ordinary income¥4.9bn2021-04-01 → 2022-03-31Cons.Ordinary income
Profit before tax¥6.2bn2021-04-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)¥4.3bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income¥4.3bn2021-04-01 → 2022-03-31Cons.Profit loss
Total assets¥83.3bnat 2022-03-31Cons.Assets
Total liabilities¥34.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥48.9bnat 2022-03-31Cons.Net assets
Net assets / equity¥44.5bnat 2021-03-31Cons.Net assets
Cash and deposits¥12.1bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥17.1bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥10.5bnat 2021-03-31Cons.Cash and cash equivalents
Operating cash flow¥2.8bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities
Investing cash flow¥6.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investment activities
Financing cash flow−¥3.0bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥151.222021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
Net assets per share¥1,734.8at 2022-03-31Cons.Net assets per share (5-year summary)
Equity ratio58.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
ROE8.8%2021-04-01 → 2022-03-31Cons.Rate of return on equity (5-year summary)
Employees777at 2022-03-31Cons.Number of employees
Revenue¥1.4bn2021-04-01 → 2022-03-31StandaloneOperating revenue1
Operating income¥717m2021-04-01 → 2022-03-31StandaloneOperating income
Ordinary income¥717m2021-04-01 → 2022-03-31StandaloneOrdinary income
Profit before tax¥717m2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Net income¥682m2021-04-01 → 2022-03-31StandaloneProfit loss
Total assets¥41.3bnat 2022-03-31StandaloneAssets
Total liabilities¥606mat 2022-03-31StandaloneLiabilities
Net assets / equity¥40.7bnat 2022-03-31StandaloneNet assets
Cash and deposits¥820mat 2022-03-31StandaloneCash and deposits
EPS (basic)¥23.792021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
Dividend per share¥152021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Net assets per share¥1,443.94at 2022-03-31StandaloneNet assets per share (5-year summary)
Equity ratio98.5%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
ROE1.7%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
Shares issued30,563,199at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Employees74at 2022-03-31StandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 24
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2021-04-01 → 2022-03-31¥5m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2022-03-3148 pure
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2022-03-31¥5.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2022-03-31¥5.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2022-03-31¥73m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment assetsat 2022-03-31¥3.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2022-03-31¥360m
Reconciling Itemsreconcilingdepreciation2021-04-01 → 2022-03-31¥136m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2022-03-31−¥73m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2022-03-31−¥73m
Reconciling Itemsreconcilingsegment assetsat 2022-03-31¥37.3bn
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2022-03-31−¥653m
Pharmaceutical Businessreportable segmentdepreciation2021-04-01 → 2022-03-31¥2.5bn
Pharmaceutical Businessreportable segmentemployeesat 2022-03-31649 pure
Pharmaceutical Businessreportable segmentrevenue2021-04-01 → 2022-03-31¥50.8bn
Pharmaceutical Businessreportable segmentrevenue external2021-04-01 → 2022-03-31¥50.8bn
Pharmaceutical Businessreportable segmentsegment assetsat 2022-03-31¥42.9bn
Pharmaceutical Businessreportable segmentsegment profit2021-04-01 → 2022-03-31¥5.1bn
Total Of Reportable Segments And Otherssegment totaldepreciation2021-04-01 → 2022-03-31¥2.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2022-03-31¥56.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2022-03-31¥56.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2022-03-31¥73m
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2022-03-31¥46.0bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2022-03-31¥5.4bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,041
ItemContextValueUnit
Total changes of items during the periodCurrentYearDuration_CapitalStockMember－JPY
Total changes of items during the periodCurrentYearDuration_CapitalSurplusMember938000000JPY
Total changes of items during the periodCurrentYearDuration_RetainedEarningsMember4043000000JPY
Total changes of items during the periodCurrentYearDuration_TreasuryStockMember-1339000000JPY
Total changes of items during the periodCurrentYearDuration_ShareholdersEquityMember3642000000JPY
Net assetsCurrentYearInstant_CapitalStockMember1197000000JPY
Net assetsCurrentYearInstant_CapitalSurplusMember1867000000JPY
Net assetsCurrentYearInstant_RetainedEarningsMember45833000000JPY
Net assetsCurrentYearInstant_TreasuryStockMember-3479000000JPY
Net assetsCurrentYearInstant_ShareholdersEquityMember45419000000JPY
Net assetsPrior1YearInstant_ValuationDifferenceOnAvailableForSaleSecuritiesMember2824000000JPY
Net assetsPrior1YearInstant_ForeignCurrencyTranslationAdjustmentMember-47000000JPY
Net assetsPrior1YearInstant_RemeasurementsOfDefinedBenefitPlansMember-44000000JPY
Net assetsPrior1YearInstant_ValuationAndTranslationAdjustmentsMember2733000000JPY
Net assetsPrior1YearInstant44510000000JPY
Increase decrease by share transfersCurrentYearDuration－JPY
Dividends from surplusCurrentYearDuration-398000000JPY
Profit loss attributable to owners of parentCurrentYearDuration4290000000JPY
Purchase of treasury stockCurrentYearDuration-318000000JPY
Disposal of treasury stockCurrentYearDuration117000000JPY
Change of scope of equity methodCurrentYearDuration_ForeignCurrencyTranslationAdjustmentMember47000000JPY
Change of scope of equity methodCurrentYearDuration_ValuationAndTranslationAdjustmentsMember47000000JPY
Change of scope of equity methodCurrentYearDuration0JPY
Net changes of items other than shareholders equityCurrentYearDuration_ValuationDifferenceOnAvailableForSaleSecuritiesMember406000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_ForeignCurrencyTranslationAdjustmentMember164000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_RemeasurementsOfDefinedBenefitPlansMember121000000JPY
Net changes of items other than shareholders equityCurrentYearDuration_ValuationAndTranslationAdjustmentsMember692000000JPY
Net changes of items other than shareholders equityCurrentYearDuration692000000JPY
Total changes of items during the periodCurrentYearDuration_ValuationDifferenceOnAvailableForSaleSecuritiesMember406000000JPY
Total changes of items during the periodCurrentYearDuration_ForeignCurrencyTranslationAdjustmentMember211000000JPY
Total changes of items during the periodCurrentYearDuration_RemeasurementsOfDefinedBenefitPlansMember121000000JPY
Total changes of items during the periodCurrentYearDuration_ValuationAndTranslationAdjustmentsMember739000000JPY
Total changes of items during the periodCurrentYearDuration4381000000JPY
Net assetsCurrentYearInstant_ValuationDifferenceOnAvailableForSaleSecuritiesMember3231000000JPY
Net assetsCurrentYearInstant_ForeignCurrencyTranslationAdjustmentMember164000000JPY
Net assetsCurrentYearInstant_RemeasurementsOfDefinedBenefitPlansMember77000000JPY
Net assetsCurrentYearInstant_ValuationAndTranslationAdjustmentsMember3473000000JPY
Net assetsCurrentYearInstant48892000000JPY
Income before income taxesCurrentYearDuration6163000000JPY
Depreciation and amortization ope cfCurrentYearDuration2885000000JPY
Impairment loss ope cfCurrentYearDuration5953000000JPY
Increase decrease in net defined benefit liability ope cfCurrentYearDuration-566000000JPY
Increase decrease in provision for the cost of environmental measures ope cfCurrentYearDuration-820000000JPY
Interest and dividends income ope cfCurrentYearDuration-258000000JPY
Interest expenses ope cfCurrentYearDuration56000000JPY
Equity in earnings losses of affiliates ope cfCurrentYearDuration-18000000JPY
Loss gain on sales and retirement of property plant and equipment ope cfCurrentYearDuration-9419000000JPY
Loss gain on valuation of investment securities ope cfCurrentYearDuration1151000000JPY
Contract termination fees ope cfCurrentYearDuration870000000JPY
Decrease increase in notes and accounts receivable trade ope cfCurrentYearDuration-1361000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identitynon_consolidated 2022-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass